» Authors » R N Bluthenthal

R N Bluthenthal

Explore the profile of R N Bluthenthal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 22
Citations 862
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Goldshear J, Kitonga N, Angelo N, Cowan A, Henwood B, Bluthenthal R
Soc Sci Med . 2023 Nov; 339:116408. PMID: 37980786
Background: Unhoused people who use drugs in the United States are at risk for a variety of negative health outcomes. As the crisis of houselessness continues to impact major urban...
2.
Werb D, Bluthenthal R, Kolla G, Strike C, Kral A, Uuskula A, et al.
J Urban Health . 2017 Sep; 95(1):91-98. PMID: 28948444
No abstract available.
3.
Heinzerling K, Kral A, Flynn N, Anderson R, Scott A, Gilbert M, et al.
Drug Alcohol Depend . 2005 Jul; 81(2):167-78. PMID: 16043308
Background: Comprehensive preventive services are recommended for injection drug users (IDU), including screening tests, vaccinations, risk reduction counseling, and sterile syringes. Syringe exchange programs (SEP) may facilitate receipt of preventive...
4.
Bluthenthal R, Kral A, Gee L, Lorvick J, Moore L, Seal K, et al.
J Acquir Immune Defic Syndr . 2001 Nov; 28(3):264-9. PMID: 11694834
Objectives: To determine trends in HIV infection and risk behaviors among street-recruited self-identified gay and bisexual male injection drug users (IDUs) in San Francisco. Methods: Trends in HIV infection and...
5.
Seal K, Kral A, Gee L, MOORE L, Bluthenthal R, Lorvick J, et al.
Am J Public Health . 2001 Oct; 91(11):1842-6. PMID: 11684613
Objectives: This study sought to determine prevalence of and risk factors for nonfatal recent overdose among street-recruited injection heroin users. Methods: From August 1998 through July 1999, 1427 heroin injectors...
6.
Kral A, Bluthenthal R, Lorvick J, Gee L, Bacchetti P, Edlin B
Lancet . 2001 May; 357(9266):1397-401. PMID: 11356437
Background: Many new HIV-1 infections in the USA occur in injection drug users (IDUs). HIV-1seroconversion of IDUs is mainly associated with injection-related risk factors. Harm- reduction programmes concentrate on injection-risk...
7.
Bluthenthal R, Gogineni A, Longshore D, Stein M
Drug Alcohol Depend . 2001 Apr; 62(3):225-30. PMID: 11295327
To determine if frequent needle-exchange program (NEP) use is associated with lower readiness to change drug use, NEP clients in Providence, RI were interviewed regarding their drug use, HIV risk,...
8.
Galvan F, Bing E, Bluthenthal R
J Acquir Immune Defic Syndr . 2001 Mar; 25 Suppl 2:S151-6. PMID: 11256736
With the many recent improvements in the medical management of HIV, the benefits of early detection of the virus have increased. People found to be HIV-positive can be offered immediate...
9.
Longshore D, Bluthenthal R, Stein M
AIDS Educ Prev . 2001 Mar; 13(1):78-90. PMID: 11252456
Needle sharing has long been recognized as a primary route of HIV infection. However, recent research has shown that HIV antibody is also detectable in injection supplies other than needles....
10.
Bluthenthal R, Kral A, Gee L, Erringer E, Edlin B
AIDS . 2000 Apr; 14(5):605-11. PMID: 10780722
Objective: To determine whether syringe exchange program use is associated with cessation of syringe sharing among high-risk injection drug users. Design And Methods: Between 1992 and 1996, street-recruited injection drug...